ResMed (RMD) Misses Q3 EPS by 2c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $220.05 +3.83%
Financial Fact:
Basic weighted average shares outstanding: 140.79M
Today's EPS Names:
VGAS, GBR, OPTX, More
Financial Fact:
Basic weighted average shares outstanding: 140.79M
Today's EPS Names:
VGAS, GBR, OPTX, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $2.37, $0.02 worse than the analyst estimate of $2.39. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.29 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fluent (FLNT) Tops Q2 EPS by 4c
- Metagenomi, Inc. (MGX) Tops Q2 EPS by 5c
- DiaMedica Therapeutics Inc. (DMAC) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
